Keytruda Before, After Surgery Improves Outcome in TNBC Results from KEYNOTE-522 show "practice-changing" impact on EFS Jul 15, 2021
Raise a Glass? Study Tallies Cancer Cases From Booze Heavy drinking habits accounted for about half of new alcohol-associated cases Jul 13, 2021
Start Thinking 'Cure'; One More Hug; Mortgages and Breast Cancer Survival News, features, and commentary about cancer-related issues Jun 16, 2021
COVID Vaccine Protection; 'Until You Die From the Cancer'; What's Palliative Care? News, features, and commentary about cancer-related issues Jun 10, 2021
Bispecific Antibody Active in NRG1-Positive Pancreatic Cancer Zenocutuzumab turns in promising results in early-phase trial involving multiple solid tumors Jun 10, 2021
More Support for Gene Assay to Guide Breast Cancer Treatment More nuanced data on treatment de-escalation, extended endocrine therapy Jun 09, 2021
Novel CDK 4/6 Inhibitor Proves Mettle in HR+/HER2- Advanced Breast Cancer Dalpiciclib may be a new treatment option; palbociclib and ribociclib continue to shine Jun 06, 2021
Olaparib Wins in Early BRCA-Mutant Breast Cancer First trial to show adjuvant PARP inhibitor benefit inBRCA mutation carriers Jun 03, 2021
Lymph Node Findings on PET: Cancer or COVID Vaccine? Post-jab radiotracer uptake "could prompt unnecessary biopsies and treatments" May 26, 2021
RET Fusion Inhibitor Active Beyond Lung, Thyroid Cancers Responses to selpercatinib in almost half of tumors outside approved indications May 21, 2021
Breast Cancer and MS: New Data Shed Light on Survival Study compares breast cancer patients with and without MS May 19, 2021
A Call for Nuance in Cardioprotection With Early Breast Cancer Therapy Longer-term PRADA trial results weigh in for low-risk group May 16, 2021
Impressive Disease Control in Metastatic Triple-Negative Breast Cancer ESMO Breast: Reassuring safety data for dual anti-HER2 therapy, antibody-drug conjugate May 14, 2021
Chemo-Free Regimen Shows Promise in High-Risk Early Breast Cancer PFS and other outcomes with letrozole-palbociclib almost identical to chemotherapy May 12, 2021
SBRT Safe for Cancer Patients With Multiple Metastases Late adverse events in phase I trial indicate need for extended follow-up May 03, 2021
New Clues to Sleep Problems, Solutions in Cancer Patients Studies in GI and breast cancers zero in on sleep disturbance during active treatment Apr 30, 2021
Healthy Lifestyle May Mitigate Heart Risks for Young Cancer Survivors Literature reviews find particularly persistent cardiovascular complications in these patients Apr 28, 2021
Chemotherapy Nausea Linked to Stress, Neuropsych Symptoms High frequency of CIN leads to stress and more severe neuropsychological symptoms Apr 23, 2021
Auricular Acupressure May Relieve Neuropathy in Breast Cancer First randomized trial of the noninvasive technique in such patients Apr 22, 2021
Are Post-Mastectomy Lymphedema Precautions Needed for All? Standard risk reduction efforts may not decrease incidence, researchers say Apr 21, 2021
Triple-Negative Breast Cancers Not All the Same Histology tied to treatment response, outcomes Apr 12, 2021
Safety Reassurance for Major Class of Diabetes Drugs Pooled trial data show no link to breast cancer Mar 24, 2021
Time to Revisit Distant Nodal Status in Breast Cancer Curability? Comparable survival for distant and regional nodal involvement, when treated similarly Mar 16, 2021
PD-1 Inhibitor Falls Short in Triple-Negative Breast Cancer No survival benefit with pembrolizumab vs chemotherapy in second-, third-line treatment Mar 08, 2021
New Targeted Therapies Show Promise in Cancer Selected abstracts from the ESMO Targeted Anticancer Therapies virtual meeting Mar 03, 2021
Mammo Study: One Saves Lives, More Exams Save More Lives Risk of fatal breast cancer decreases with increasing participation in screening Mar 02, 2021
FDA Panel Slows the Roll for Pembrolizumab in Breast Cancer Advisory committee: Wait for more data before considering neoadjuvant indication Feb 09, 2021
Has Pembrolizumab Finally Met an Indication FDA Doesn't Like? Agency staff skeptical of data in early breast cancer Feb 08, 2021
Optimizing Neoadjuvant Therapy for Breast Cancer ASCO guideline covers patient selection, treatment options, follow-up Feb 02, 2021
Cancer and COVID; Booze and Cancer; 'Screech' Starts Chemo News, features, and commentary about cancer-related issues Jan 21, 2021
Oncotype DX Misses on Breast Cancer Risk in Black Women Accuracy of 21-gene recurrence score worse compared with white women Jan 21, 2021
Not Just BRCA: Large Studies ID Other Key Breast Cancer Risk Genes Implications for screening and other risk-management strategies, researchers say Jan 20, 2021
Most Women Satisfied With 'Going Flat' After Mastectomy Lack of surgeon support key factor in later dissatisfaction, study shows Jan 08, 2021
PARP Inhibitors Linked With Blood Cancer Risk Incidence of MDS/AML under 1%, but further investigation warranted as indications broaden Dec 28, 2020
Add-On HDAC Inhibitor No Help in Breast Cancer PFS, OS similar to endocrine therapy alone for advanced HR+ disease Dec 15, 2020
Broader Role for PARP Inhibitors in Breast Cancer? Responses in tumors with somatic or germline mutations related to HRD Dec 14, 2020
Online Tool Refines Individual Risks in Breast Cancer RSClin incorporates 21-gene recurrence score with tumor grade, size, and more Dec 13, 2020
Doctor-Patient Discord in Reporting Radiation Toxicity Physicians underrecognized substantial symptoms in more than half of patients Dec 11, 2020
Adjuvant Palbociclib Fails in Early, High-Risk Breast Cancer No iDFS benefit with 1 year of CDK4/6 inhibition following neoadjuvant chemotherapy Dec 10, 2020
